OrbusNeich Medical Group Holdings Limited
6929.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.14B
Close$
$6.39
67.6% upside
Current Fair Value
67.6% upsideUndervalued by 67.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.14 Billion |
|---|---|
| Enterprise Value | $2.95 Billion |
| Dividend Yield | $0.27 (5.24%) |
| Earnings per Share | $0.05 |
| Beta | -0.63 |
| Outstanding Shares | 823,253,000 |
Return
| Return on Equity | 20.16% |
|---|---|
| Return on Assets | 18.34% |
| Return on Invested Capital | 18.42% |
Valuation & Multiples
| P/E Ratio | 9.08 |
|---|---|
| PEG | 103.73 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 8.11 |
| Enterprise Value to EBIT | 37.51 |
| Enterprise Value to Net Income | 35 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$772.30 M
Average shareholder expectationNext Earnings Call
Expected Date
March 11, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$847.79 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About OrbusNeich Medical Group Holdings Limited
1,528 employees
CEO: David Chien OrbusNeich Medical Group Holdings Limited functions as an investment holding entity, specializing in the development, distribution, sales, and marketing of medical instruments tailored for treating coronary and peripheral vascular ailmen...